Setareh studied medicine at the University of Gothenburg, Sweden before completing her UK foundation programme in Cambridge. Between 2020-2024 she completed her DPhil in Congenital Myasthenic Syndrome (CMS) at the University of Oxford where she explored the effect of allosteric modulation of nAChRs using single cell patch clamping. She also explored potential novel therapies for CMS using AAV9 gene therapy in mouse models for disease. She joined Prof Rita Horvath´s lab in 2025 as an Academic Clinical Fellow in neurology. Her research interests lie in CMS/myasthenia but also to better understand how mitochondrial diseases affect the neuromuscular junction transmission. She also has an interest in global medicine and currently works in collaboration with centres in Asia, South America and Africa.